Heart Disease Clinical Trials in Arizona

Showing 101-120 of 200 trials

TERMINATEDNA31 miles

Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System

NCT03102437

This is a multicenter, prospective, single-arm Continued Access study of the Optimizer Smart System with CCM therapy.

Heart FailureCongestive Heart FailureChronic Heart Disease+1 more

Impulse Dynamics106 participantsStarted Jul 2017

Mesa, Arizona, United States • Mesa, Arizona, United States • Phoenix, Arizona, United States +14 more locations

COMPLETED31 miles

St. Jude Medical Product Longevity and Performance (SCORE) Registry

NCT01754064

SCORE is an active, prospective, non-randomized, multi-center outcome-oriented registry of patients implanted with St Jude Medical (SJM) market-released cardiac rhythm management (CRM) products. This registry will be conducted in the United States (US). The primary purpose of the registry is to evaluate and publish acute and long-term performance of market-released SJM CRM products by analyzing product survival probabilities. Product status and any related adverse events will be collected to measure survival probabilities.

BradycardiaTachycardiaHeart Disease

Abbott Medical Devices10,957 participantsStarted Nov 2007

Huntsville, Alabama, United States • Mobile, Alabama, United States • Anchorage, Alaska, United States +77 more locations

Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System

St. Jude Medical Product Longevity and Performance (SCORE) Registry

Heart Disease Trials in Other Cities

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

Restore EF Observational Study

Stop Atherosclerosis in Native Diabetics Study

SynCardia 70cc TAH-t for Destination Therapy (DT)

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

Imaging of Coronary Plaques in Participants Treated With Evolocumab

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

Early Elimination of Premature Ventricular Contractions in Heart Failure

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

A Study of CLR325 in Chronic Stable Heart Failure Patients.

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

Other Conditions in Arizona